#medicines

"An international research team has found almost a million potential sources of antibiotics in the natural world.

Research published in the journal Cell by a team including Queensland University of Technology (QUT) computational biologist Associate Professor Luis Pedro Coelho has used machine learning to identify 863,498 promising antimicrobial peptides -- small molecules that can kill or inhibit the growth of infectious microbes.

The findings of the study come with a renewed global focus on combatting antimicrobial resistance (AMR) as humanity contends with the growing number of superbugs resistant to current drugs.

"There is an urgent need for new methods for antibiotic discovery," Professor Coelho, a researcher at the QUT Centre for Microbiome Research, said. The centre studies the structure and function of microbial communities from around the globe.

"It is one of the top public health threats, killing 1.27 million people each year." ...

"Using artificial intelligence to understand and harness the power of the global microbiome will hopefully drive innovative research for better public health outcomes," he said.

The team verified the machine predictions by testing 100 laboratory-made peptides against clinically significant pathogens. They found 79 disrupted bacterial membranes and 63 specifically targeted antibiotic-resistant bacteria such as Staphylococcus aureus and Escherichia coli.

"Moreover, some peptides helped to eliminate infections in mice; two in particular reduced bacteria by up to four orders of magnitude," Professor Coelho said.

In a preclinical model, tested on infected mice, treatment with these peptides produced results similar to the effects of polymyxin B -- a commercially available antibiotic which is used to treat meningitis, pneumonia, sepsis and urinary tract infections.

More than 60,000 metagenomes (a collection of genomes within a specific environment), which together contained the genetic makeup of over one million organisms, were analysed to get these results. They came from sources across the globe including marine and soil environments, and human and animal guts.

The resulting AMPSphere -- a comprehensive database comprising these novel peptides -- has been published as a publicly available, open-access resource for new antibiotic discovery.

[Note: !!! Love it. Open access research databases my beloved.]"

A re-elected Labor Government will make every PBS - Pharmaceutical Benefits Scheme - medicine cost no more than $25 a script !!!!

Public health and access to medicine and medical care is a human right

This is incredible

Please make sure you vote Labor, for yourself and for everyone- including the environment

Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository manufacturer in India | centurionhealthcare

Centurion Healthcare Private Limited is a trusted Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository manufacturer in India, committed to delivering high-quality pharmaceutical solutions. We are a leading Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository supplier in India, catering to hospitals, clinics, and distributors with products that meet international quality standards. As a reliable Phloroglucinol 150 mg + Trimethylphloroglucinol 150 mg suppository exporter in India, we ensure timely delivery and safe packaging for domestic and global clients. Partner with us for premium-quality suppositories crafted with precision and care.

Midol, Mistress Of The Crimson Tides.

Prozac, Crusader Of Sorrows.